Key facts
- It has raised $2.0M; the latest was Seed Round ($2.0M) in Mar 2025.
- Notable investors include Gaingels.
- Status: Privately Held (backing).
Leadership
- German EcheverryChief Executive Officer & Founder
- Giancarlo ZabaletaChief Technology Officer & Founder
- Shayan ShamsChief Operating Officer & Founder
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Tuyo Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Tuyo Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Tuyo Health
Developer of a telehealth platform designed for personalized wellness and chronic condition management. The company's platform integrates digital health assessments to facilitate the distribution of GLP-1 weight loss medications, hormone replacement therapies, and sexual health treatments, enabling patients to access discreet medical consultations and science-backed pharmaceuticals from home without the logistical barriers of traditional in-person clinical visits.
- Sector
- Healthcare
- HQ
- Miami, FL, United States
- Founded
- 2024
- Employees
- 9
- Website
- tuyohealth.com/
- Ownership
- Privately Held (backing)
Tuyo Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Tuyo Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Tuyo Health in its N-PORT filings yet. We sweep new filings monthly.